World's Best Scientists 2026 revealed!
Lars Mathiesen

Lars Mathiesen

Lars Mathiesen publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Lars Mathiesen sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

The last bar groups every scientist with 807 publications or more.

Lars Mathiesen D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Lars Mathiesen sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

The last bar groups every scientist with 157 D-Index or more.

Overview

Lars Mathiesen is affiliated with Hvidovre Hospital in Denmark and has contributed extensively to research in medicine and environmental science. Their work spans several subfields including pediatrics, perinatology and child health, health toxicology and mutagenesis, public health, environmental and occupational health, obstetrics and gynecology, and genetics. The main topics of their research focus on birth, development, and health, pregnancy and preeclampsia studies, toxic organic pollutants impact, effects and risks of endocrine disrupting chemicals, assisted reproductive technology and twin pregnancy, pregnancy and medication impact, and maternal mental health during pregnancy and postpartum.

Mathiesen's recent publications reflect their involvement in studies examining environmental exposures and placental function. Notable papers include:

  • Fetal exposure to environmental chemicals; insights from placental perfusion studies, 2021, Placenta
  • Telomere length in newborns is associated with exposure to low levels of air pollution during pregnancy, 2020, Environment International
  • Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria, 2024, Nature Communications
  • Ex vivo dual perfusion of an isolated human placenta cotyledon: Towards protocol standardization and improved inter-centre comparability, 2022, Placenta
  • Placental transfer of pesticides studied in human placental perfusion, 2020, Basic & Clinical Pharmacology & Toxicology

Mathiesen frequently publishes in scientific journals such as Placenta, Basic & Clinical Pharmacology & Toxicology, Environment International, Nature Communications, and PLoS ONE. Most of their work appears in Placenta and Basic & Clinical Pharmacology & Toxicology, where they have multiple publications.

Their collaborative research network includes frequent coauthors such as Lisbeth E. Knudsen, Dea Sandal, Bjarne Styrishave, Tina Buerki-Thurnherr, and Leonie Aengenheister.

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • A Controlled Trial of Zidovudine in Primary Human Immunodeficiency Virus Infection

    Sabine Kinloch De Loës;Bernard J. Hirschel;Bruno Hoen;David A. Cooper

  • Latent Tuberculosis in HIV positive, diagnosed by the M. Tuberculosis Specific Interferon-γ test

    Inger Brock;Morten Ruhwald;Bettina Lundgren;Henrik Westh

  • Syphilis and human immunodeficiency virus (HIV)-1 coinfection: influence on CD4 T-cell count, HIV-1 viral load, and treatment response.

    Kristian Kofoed;Jan Gerstoft;Lars R Mathiesen;Thomas Benfield

  • Autologous HIV-1 neutralizing antibodies: emergence of neutralization-resistant escape virus and subsequent development of escape virus neutralizing antibodies.

    Maiken Arendrup;Claus Nielsen;John-Erik Stig Hansen;Court Pedersen

  • Inhibition of human immunodeficiency virus (HIV) infection in vitro by anticarbohydrate monoclonal antibodies: peripheral glycosylation of HIV envelope glycoprotein gp120 may be a target for virus neutralization.

    J E Hansen;H Clausen;C Nielsen;L S Teglbjaerg

  • Development of cytomegalovirus (CMV) disease may be predicted in HIV-infected patients by CMV polymerase chain reaction and the antigenemia test.

    Karen Kaae Dodt;Palle Høy Jacobsen;Bo Hofmann;Christian Meyer

  • Enzyme-Linked Immunosorbent Assay for Detection of Hepatitis A Antigen in Stool and Antibody to Hepatitis A Antigen in Sera: Comparison with Solid-Phase Radioimmunoassay, Immune Electron Microscopy, and Immune Adherence Hemagglutination Assay

    Lars R. Mathiesen;Stephen M. Feinstone;Doris C. Wong;Peter Skinhoej

  • Correlation between carbohydrate structures on the envelope glycoprotein gp120 of HIV-1 and HIV-2 and syncytium inhibition with lectins.

    Hansen Je;Nielsen Cm;Nielsen C;Heegaard P

  • Broadly neutralizing antibodies targeted to mucin-type carbohydrate epitopes of human immunodeficiency virus.

    J E Hansen;C Nielsen;M Arendrup;S Olofsson

  • Localization of Hepatitis A Antigen in Marmoset Organs during Acute Infection with Hepatitis A Virus

    Lars R. Mathiesen;Jacques Drucker;Douglas Lorenz;JoAnn Wagner

  • A preliminary report on the neuropsychologic sequelae of human immunodeficiency virus.

    Susanne Lunn;Marianne Skydsbjerg;Hanne Schulsinger;Josef Parnas

  • Detection of hepatitis A antigen by immunofluorescence.

    L R Mathiesen;S M Feinstone;R H Purcell;J A Wagner

  • Hepatitis type A, B, and non-A non-B in fulminant hepatitis.

    L R Mathiesen;P Skinoj;J O Nielsen;R H Purcell

  • Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial.

    Ole Kirk;Terese L. Katzenstein;Jan Gerstoft;Lars Mathiesen

  • Anal and cervical abnormality in women--prediction by human papillomavirus tests.

    Mads Melbye;Else Smith;Jan Wohlfahrt;Anne Østerlind

  • HIV-induced immunodeficiency. Relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly preserved responses via CD2/phytohemagglutinin pathway.

    B Hofmann;K D Jakobsen;N Odum;E Dickmeiss

  • Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.

    Jan Gerstoft;Ole Kirk;Niels Obel;Court Pedersen

  • K65R with and without S68: a new resistance profile in vivo detected in most patients failing abacavir, didanosine and stavudine.

    Birgit T Røge;Terese L Katzenstein;Niels Obel;Henrik Nielsen

  • Presence and meaning of anti-HBc IgM as determined by ELISA in patients with acute type B hepatitis and healthy HBsAg carriers.

    P Kryger;L R Mathiesen;J Aldershville;J O Nielsen

Frequent Co-Authors

Jan Gerstoft
Jan Gerstoft Rigshospitalet
Court Pedersen
Court Pedersen Odense University Hospital
Peter Skinhøj
Peter Skinhøj Copenhagen University Hospital
Robert H. Purcell
Robert H. Purcell National Institute of Allergy and Infectious Diseases
Nathan Clumeck
Nathan Clumeck Université Libre de Bruxelles
David A. Cooper
David A. Cooper University of New South Wales
Maiken Cavling Arendrup
Maiken Cavling Arendrup Statens Serum Institut
Thomas Benfield
Thomas Benfield Copenhagen University Hospital
Adriano Lazzarin
Adriano Lazzarin Vita-Salute San Raffaele University
Eric Sandström
Eric Sandström Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Immunology in the USA opens doors to various healthcare and scientific career paths, often requiring complementary clinical education. Many students explore specialized nursing programs to enhance their expertise while focusing on immunological health issues.

For those transitioning from non-nursing backgrounds, accelerated bsn programs for non nurses provide an efficient route to enter nursing with a solid foundation. These programs blend rigorous study with faster timelines, catering to career changers eager to integrate clinical immunology knowledge.

Entry-level candidates might consider easy lpn programs to get into, which offer accessible pathways into practical nursing. Gaining hands-on experience here can be a springboard toward advanced clinical roles involving immunological care and patient management.

For advanced clinical roles, exploring nurse practitioner programs with easy admission can facilitate specialization in immunology-related practice areas. These programs emphasize both theoretical and clinical training, essential for managing complex immune disorders.

Mental health nursing with a focus on psychiatric care and immunology intersections is another growing field. Enrolling in top online pmhnp programs ensures strong clinical placements and prepares students for impactful careers addressing immune-related psychiatric conditions.

Best Scientists Citing Lars Mathiesen

Trending Scientists

Recently Published Articles